CR Intrinsic Investors’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q4
Sell
-270,592
Closed -$4.14M 435
2013
Q3
$4.14M Buy
+270,592
New +$4.14M 0.13% 203